Search

Showing "11155" results for ""

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

Darunavir: negative interactions with Kaletra, Viagra and contraceptive pill reported

CXCR4, dual or mixed tropic HIV does not reduce response to HAART

EU survey finds widespread ignorance of HIV transmission risks

Higher baseline HCV viral load and CD4 percentage predict response to hepatitis C treatment in HIV/HCV co-infected patients

Anti-HIV therapy suppresses viral load well in older patients, but CD4 cell recovery may be impaired

Community-acquired MRSA soars among people with HIV in San Francisco

Kaletra, saquinavir have anti-malarial effects in test tube

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

Needle-free administration of enfuvirtide reduces injection site reactions

Hepatitis C infection limits cholesterol increases caused by antiretrovirals

Darunavir response did not differ by prior PI in POWER studies

Lab markers can predict advanced liver fibrosis in more than 90% of cases in HIV/HCV coinfected

Two-drug maintenance with tenofovir-efavirenz less effective than triple therapy

HIV diagnosis leads to significant reduction in risky behaviour in African sex workers

THT wants votes for Labour's policy-making website by Friday 13th October

Continuing 3TC therapy after viral rebound shows no benefit

Receive the latest HIV research and conference news

Showing "11155" results for ""

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

Darunavir: negative interactions with Kaletra, Viagra and contraceptive pill reported

CXCR4, dual or mixed tropic HIV does not reduce response to HAART

EU survey finds widespread ignorance of HIV transmission risks

Higher baseline HCV viral load and CD4 percentage predict response to hepatitis C treatment in HIV/HCV co-infected patients

Anti-HIV therapy suppresses viral load well in older patients, but CD4 cell recovery may be impaired

Community-acquired MRSA soars among people with HIV in San Francisco

Kaletra, saquinavir have anti-malarial effects in test tube

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

Needle-free administration of enfuvirtide reduces injection site reactions

Hepatitis C infection limits cholesterol increases caused by antiretrovirals

Darunavir response did not differ by prior PI in POWER studies

Lab markers can predict advanced liver fibrosis in more than 90% of cases in HIV/HCV coinfected

Two-drug maintenance with tenofovir-efavirenz less effective than triple therapy

HIV diagnosis leads to significant reduction in risky behaviour in African sex workers

THT wants votes for Labour's policy-making website by Friday 13th October

Continuing 3TC therapy after viral rebound shows no benefit

Receive the latest HIV research and conference news